Translational Rational for the Clinical Development of OTX-008: A Novel Drug That Inhibits Galectin-1 Expression in Human Cancer Models in Galectins and Disease Implications for Targeted Therapeutics.

Raymond E, Astrorgue-Xerri L, Serova M, Riveiro ME, Faivre S. Chapter 15, pp 259–266 ACS Symposium Series, Vol. 1115. ISBN13: 9780841228801. eISBN: 9780841228818. December 18, 2012 Book Chapter.  

Single agent and combination studies of pralatrexate and molecular correlates of sensitivity.

Serova M, Bieche I, Sablin MP, Pronk GJ, Vidaud M, Cvitkovic E, Faivre S, Raymond E.  Br J Cancer . 2011;104(2):272-80.

Serova M, Astorgues-Xerri L, Bieche I, Albert S, Vidaud M, Benhadji KA, Emami S, Vidaud D, Hammel P, Theu-Anton N, Gespach C, Faivre S, Raymond E.

Epithelial-to-Mesenchymal Transition and Oncogenic Ras Expression in Resistance to the Protein Kinase Cß Inhibitor Enzastaurin in Colon Cancer Cells. Mol Cancer Ther. 2010 May;9(5):1308-17.

1 2 3 4 5 6 7
Clikeo Agence Clikeo